Boundless Bio Inc (NASDAQ:BOLD) does about 111.46K shares in volume on a normal day but saw 1130949 shares change hands in the recent trading day. The company now has a market cap of 24.18M USD. Its current market price is $1.08, marking an increase of 4.85% compared to the previous close of $1.03. The 52 week high reached by this stock is $5.88 whilst the lowest price level in 52 weeks is $1.01.
The consensus objective for the share price is $4.00, suggesting that the stock has a potential upside of 73.0% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on June 02, 2025 when H.C. Wainwright initiated the stock to “Buy” and issued a price target of $5. Leerink Partners downgraded the stock to “Market Perform” from Outperform on May 28, 2025 at a price target of $3.
The current price level is -2.92%, -20.47%, and -52.21% away from its SMA20, SMA50, and SMA200 respectively, with the BOLD price moving above the 50-day SMA on current market day. Boundless Bio Inc (BOLD) stock is down -0.92% over the week and -30.77% over the past month. Its price is -80.36% year-to-date and -62.76% over the past year.
To reach the target analysts have set, the stock logically needs to grow 73.0 percent from here.
Outstanding shares total 22.30M with insiders holding 11.40% of the shares and institutional holders owning 70.35% of the company’s common stock. The company has a return on investment of -35.53% and return on equity of -54.06%. The beta has a value of -0.76. Price to book ratio is 0.18.
